BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10669929)

  • 1. Increased expression of VE-cadherin correlates temporally with differentiation of a restrictive endothelial barrier during normal angiogenesis in vivo.
    Cruz A; DeFouw DO
    Tissue Cell; 1999 Dec; 31(6):545-9. PubMed ID: 10669929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
    DeFouw LM; DeFouw DO
    Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive endothelial barrier function during normal angiogenesis in vivo: partial dependence on tyrosine dephosphorylation of beta-catenin.
    Cruz A; DeFouw LM; DeFouw DO
    Microvasc Res; 2000 Mar; 59(2):195-203. PubMed ID: 10684725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential phosphodiesterase activity contributes to restrictive endothelial barrier function during angiogenesis.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2001 Nov; 62(3):263-70. PubMed ID: 11678629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential lectin binding to microvascular endothelial glycoconjugates during normal angiogenesis in the chick chorioallantoic membrane.
    Henry CB; DeFouw DO
    Microvasc Res; 1995 Mar; 49(2):201-11. PubMed ID: 7541505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
    Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
    Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
    Martin TA; Mansel R; Jiang WG
    Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking the VE-cadherin bonds.
    Gavard J
    FEBS Lett; 2009 Jan; 583(1):1-6. PubMed ID: 19059243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing intercellular interactions between vascular endothelial cadherin pairs at single-molecule resolution and in living cells.
    Panorchan P; George JP; Wirtz D
    J Mol Biol; 2006 May; 358(3):665-74. PubMed ID: 16540120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmalemmal concentration and affinity of mouse vascular endothelial cadherin, VE-cadherin.
    Baumgartner W; Drenckhahn D
    Eur Biophys J; 2002 Dec; 31(7):532-8. PubMed ID: 12451422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken.
    Gerhardt H; Wolburg H; Redies C
    Dev Dyn; 2000 Jul; 218(3):472-9. PubMed ID: 10878612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
    Ribatti D; Vacca A; Roncali L; Dammacco F
    Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial VE-cadherin expression in human lungs.
    Herwig MC; Müller KM; Müller AM
    Pathol Res Pract; 2008; 204(10):725-30. PubMed ID: 18639387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.